<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ateroskleroz</journal-id><journal-title-group><journal-title xml:lang="ru">Атеросклероз</journal-title><trans-title-group xml:lang="en"><trans-title>Ateroscleroz</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2078-256X</issn><issn pub-type="epub">2949-3633</issn><publisher><publisher-name>НИИТПМ-филиал ИЦиГ СО РАН</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.52727/2078-256X-2023-19-3-271-274</article-id><article-id custom-type="elpub" pub-id-type="custom">ateroskleroz-970</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>МАТЕРИАЛЫ ВТОРОЙ ВСЕРОССИЙСКОЙ КОНФЕРЕНЦИИ С МЕЖДУНАРОДНЫМ УЧАСТИЕМ «ФУНДАМЕНТАЛЬНЫЕ АСПЕКТЫ АТЕРОСКЛЕРОЗА: НАУЧНЫЕ ИССЛЕДОВАНИЯ ДЛЯ СОВЕРШЕНСТВОВАНИЯ ТЕХНОЛОГИЙ ПЕРСОНАЛИЗИРОВАННОЙ МЕДИЦИНЫ», г. Новосибирск, 12 октября 2023 г.</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>MATERIALS OF THE SECOND ALL-RUSSIAN CONFERENCE WITH INTERNATIONAL PARTICIPATION “FUNDAMENTAL ASPECTS OF ATHEROSCLEROSIS: SCIENTIFIC RESEARCH TO IMPROVE TECHNOLOGIES OF PERSONALIZED MEDICINE”, October 12, 2023, Novosibirsk</subject></subj-group></article-categories><title-group><article-title>Молекулярно-генетические маркеры (ген APOE) и депрессия среди лиц 25–64 лет (международная программа ВОЗ «MONICA-PSYCHOSOCIAL»)</article-title><trans-title-group xml:lang="en"><trans-title></trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гафаров</surname><given-names>В. В.</given-names></name></name-alternatives><bio xml:lang="ru"><p>г. Новосибирск</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Громова</surname><given-names>Е. А.</given-names></name></name-alternatives><bio xml:lang="ru"><p>г. Новосибирск</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шахтшнейдер</surname><given-names>Е. В.</given-names></name></name-alternatives><bio xml:lang="ru"><p>г. Новосибирск</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гагулин</surname><given-names>И. В.</given-names></name></name-alternatives><bio xml:lang="ru"><p>г. Новосибирск</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гафарова</surname><given-names>А. В.</given-names></name></name-alternatives><bio xml:lang="ru"><p>г. Новосибирск</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>НИИ терапии и профилактической медицины – филиал ФГБНУ ФИЦ ИЦиГ СО РАН;&#13;
Межведомственная лаборатория эпидемиологии сердечно-сосудистых заболеваний</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-2"><institution>НИИ терапии и профилактической медицины – филиал ФГБНУ ФИЦ ИЦиГ СО РАН</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>06</day><month>10</month><year>2023</year></pub-date><volume>19</volume><issue>3</issue><fpage>271</fpage><lpage>274</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Гафаров В.В., Громова Е.А., Шахтшнейдер Е.В., Гагулин И.В., Гафарова А.В., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Гафаров В.В., Громова Е.А., Шахтшнейдер Е.В., Гагулин И.В., Гафарова А.В.</copyright-holder><copyright-holder xml:lang="en">Гафаров В.В., Громова Е.А., Шахтшнейдер Е.В., Гагулин И.В., Гафарова А.В.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://ateroskleroz.elpub.ru/jour/article/view/970">https://ateroskleroz.elpub.ru/jour/article/view/970</self-uri><abstract><p>Введение. В настоящее время распространенность депрессии составляет 3–5 %, на нее приходится второе по величине экономическое бремя болезней [1–3]. Ген аполипопротеин Е (АРОЕ) включает три аллеля: ε2, ε3 и ε4, которые могут вызывать предрасположенность к депрессии. Некоторые исследователи сообщают, что полиморфизмы гена АРОЕ являются факторами риска возникновения депрессии [<xref ref-type="bibr" rid="cit4">4</xref>]. Аллели APOE ε2, ε3 и ε4 могут объединяться, образуя шесть генотипов (гомозиготы по ε2, ε3 и ε4; гетерозиготы по ε2/3, ε2/4 и ε3/4). Частоты аллелей и генотипов различались среди разных этнических групп и географических районов [5–7]. Низкая концентрация холестерина в сыворотке связана с риском депрессии [8, 9]. У многих пациентов с депрессией наблюдается потеря нейронов и структурные аномалии головного мозга, которые могут быть результатом дислипидемии [<xref ref-type="bibr" rid="cit10">10</xref>]. У пациентов с депрессией была более высокая частота аллеля АРОЕ ε4, полиморфизм АРОЕ ε4 был фактором риска депрессии [<xref ref-type="bibr" rid="cit11">11</xref>]. По сравнению с пациентами, у которых не было аллеля ε4, у пациентов с аллелем ε4 проявлялись более выраженные симптомы депрессии [12, 13]. Таким образом, учитывая вышеизложенные факты, целью нашего исследования стало изучение связи генотипов гена APOE с депрессией среди лиц 25–64 лет г. Новосибирска.</p></abstract><funding-group><funding-statement xml:lang="ru">Работа выполнена в рамках бюджетной темы № 122031700094-5.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Yu.S., Holsboer F., Almeida O.F. Neuronal actions of glucocorticoids: focus on depression. J. Steroid. Biochem. Mol. Biol., 2008; 108: 300–309. doi: 10.1016/j.jsbmb.2007.09.014</mixed-citation><mixed-citation xml:lang="en">Yu.S., Holsboer F., Almeida O.F. Neuronal actions of glucocorticoids: focus on depression. J. Steroid. Biochem. Mol. Biol., 2008; 108: 300–309. doi: 10.1016/j.jsbmb.2007.09.014</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Mathers C.D., Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PloS Med., 2006; 3: e442–446. doi: 10.1371/journal.pmed.0030442</mixed-citation><mixed-citation xml:lang="en">Mathers C.D., Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PloS Med., 2006; 3: e442–446. doi: 10.1371/journal.pmed.0030442</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Mayberg H.S., Lozano A.M., Voon V., McNeely H.E., Seminowicz D., Hamani C., Schwalb J.M.,</mixed-citation><mixed-citation xml:lang="en">Mayberg H.S., Lozano A.M., Voon V., McNeely H.E., Seminowicz D., Hamani C., Schwalb J.M.,</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Weisenbach S.L., Boore L.A., Kales H.C. Depression and cognitive impairment in older adults. Curr. Psychiatry Rep., 2012; 14 (4): 280–288. doi: 10.1007/s11920-012-0278-7</mixed-citation><mixed-citation xml:lang="en">Weisenbach S.L., Boore L.A., Kales H.C. Depression and cognitive impairment in older adults. Curr. Psychiatry Rep., 2012; 14 (4): 280–288. doi: 10.1007/s11920-012-0278-7</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Liu Y.L., Zhang H.M., Pan H.M., Bao Y.H., Xue J., Wang T.C., Dong X.C., Li X.L., Bao H.G. The relationship between apolipoprotein E gene ε2/ε3/ε4 polymorphism and breast cancer risk: a systematic review and meta-analysis. Onco Targets Ther., 2016; 9: 1241–1249. doi: 10.2147/OTT.S94228</mixed-citation><mixed-citation xml:lang="en">Liu Y.L., Zhang H.M., Pan H.M., Bao Y.H., Xue J., Wang T.C., Dong X.C., Li X.L., Bao H.G. The relationship between apolipoprotein E gene ε2/ε3/ε4 polymorphism and breast cancer risk: a systematic review and meta-analysis. Onco Targets Ther., 2016; 9: 1241–1249. doi: 10.2147/OTT.S94228</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Bell R.D., Winkler E.A., Singh I., Sagare A.P., Deane R., Wu Z., Holtzman D.M., Betsholtz C., Armulik A., Sallstrom J., Berk B.C., Zlokovic B.V. Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature., 2012; 485 (7399): 512–516. doi: 10.1038/nature11087</mixed-citation><mixed-citation xml:lang="en">Bell R.D., Winkler E.A., Singh I., Sagare A.P., Deane R., Wu Z., Holtzman D.M., Betsholtz C., Armulik A., Sallstrom J., Berk B.C., Zlokovic B.V. Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature., 2012; 485 (7399): 512–516. doi: 10.1038/nature11087</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Seet W.T., Mary A.T.J., Yen T.S. Apolipoprotein E genotyping in the Malay, Chinese and Indian ethnic groups in Malaysia-a study on the distribution of the different APOE alleles and genotypes. Clin. Chim. Acta., 2004; 340: 201–205. doi: 10.1016/j.cccn.2003. 11.001</mixed-citation><mixed-citation xml:lang="en">Seet W.T., Mary A.T.J., Yen T.S. Apolipoprotein E genotyping in the Malay, Chinese and Indian ethnic groups in Malaysia-a study on the distribution of the different APOE alleles and genotypes. Clin. Chim. Acta., 2004; 340: 201–205. doi: 10.1016/j.cccn.2003. 11.001</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Huang Y.P., Xue J.J., Li C., Chen X., Fu H.J., Fei T., Bi P.X. Depression and APOEε4 Status in Individuals with Subjective Cognitive Decline: A Meta-Analysis. Psychiatry Investig, 2020; 17 (9): 858–864. doi: 10.30773/pi.2019.0324</mixed-citation><mixed-citation xml:lang="en">Huang Y.P., Xue J.J., Li C., Chen X., Fu H.J., Fei T., Bi P.X. Depression and APOEε4 Status in Individuals with Subjective Cognitive Decline: A Meta-Analysis. Psychiatry Investig, 2020; 17 (9): 858–864. doi: 10.30773/pi.2019.0324</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Su W.H., Shi Z.H., Liu S.L., Wang X.D., Liu S., Ji Y. Updated meta-analysis of the role of APOE ε2/ ε3/ε4 alleles in frontotemporal lobar degeneration. Oncotarget, 2017; 8 (27): 43721–43732. doi: 10.18632/oncotarget.17341</mixed-citation><mixed-citation xml:lang="en">Su W.H., Shi Z.H., Liu S.L., Wang X.D., Liu S., Ji Y. Updated meta-analysis of the role of APOE ε2/ ε3/ε4 alleles in frontotemporal lobar degeneration. Oncotarget, 2017; 8 (27): 43721–43732. doi: 10.18632/oncotarget.17341</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Maes M., Smith R., Christophe A., Vandoolaeghe E., van Gastel A., Neels H., Demedts P., Wauters A., Meltzer H.Y. Lower serum high-density lipoprotein cholesterol (HDL-C) in major depression and in depressed men with serious suicidal attempts: relationship with immune-inflammatory markers. Acta Psychiatr. Scand., 1997; 95 (3): 212–221. doi: 10.1111/j.1600-0447.1997.tb09622.x</mixed-citation><mixed-citation xml:lang="en">Maes M., Smith R., Christophe A., Vandoolaeghe E., van Gastel A., Neels H., Demedts P., Wauters A., Meltzer H.Y. Lower serum high-density lipoprotein cholesterol (HDL-C) in major depression and in depressed men with serious suicidal attempts: relationship with immune-inflammatory markers. Acta Psychiatr. Scand., 1997; 95 (3): 212–221. doi: 10.1111/j.1600-0447.1997.tb09622.x</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Löwe L.C., Gaser C., Franke K.; Alzheimer’s Disease Neuroimaging Initiative. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer’s Disease. PLoS One, 2016; 11 (7): e0157514. doi: 10.1371/journal.pone.0157514</mixed-citation><mixed-citation xml:lang="en">Löwe L.C., Gaser C., Franke K.; Alzheimer’s Disease Neuroimaging Initiative. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer’s Disease. PLoS One, 2016; 11 (7): e0157514. doi: 10.1371/journal.pone.0157514</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Choe Y.M., Suh G.H., Lee B.C., Choi I.G., Lee J.H., Kim H.S., Hwang J., Kim J.W. Brain Amyloid Index as a Probable Marker Bridging Between Subjective Memory Complaint and Objective Cognitive Performance. Front Neurosci., 2022; 16: 912891. doi: 10.3389/fnins.2022.912891</mixed-citation><mixed-citation xml:lang="en">Choe Y.M., Suh G.H., Lee B.C., Choi I.G., Lee J.H., Kim H.S., Hwang J., Kim J.W. Brain Amyloid Index as a Probable Marker Bridging Between Subjective Memory Complaint and Objective Cognitive Performance. Front Neurosci., 2022; 16: 912891. doi: 10.3389/fnins.2022.912891</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Piers R.J., Liu Y., Ang T.F.A., Tao Q., Au R., Qiu W.Q. Association Between Elevated Depressive Symptoms and Cognitive Function Moderated by APOE4 Status: Framingham Offspring Study. J. Alzheimers Dis., 2021;80(3):1269-1279. doi: 10.3233/JAD-200998. PMID: 33646152</mixed-citation><mixed-citation xml:lang="en">Piers R.J., Liu Y., Ang T.F.A., Tao Q., Au R., Qiu W.Q. Association Between Elevated Depressive Symptoms and Cognitive Function Moderated by APOE4 Status: Framingham Offspring Study. J. Alzheimers Dis., 2021;80(3):1269-1279. doi: 10.3233/JAD-200998. PMID: 33646152</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">World Health Organization. MONICA Psychosocial Optional Study. Suggested Measurement Instruments. Copenhagen: WHO Regional Office for Europe, 1988.</mixed-citation><mixed-citation xml:lang="en">World Health Organization. MONICA Psychosocial Optional Study. Suggested Measurement Instruments. Copenhagen: WHO Regional Office for Europe, 1988.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Bühl A., Zöfel P. SPSS Version 10. Einführung in die moderneDatenanalyseunter Windows, 2005, 608 p.</mixed-citation><mixed-citation xml:lang="en">Bühl A., Zöfel P. SPSS Version 10. Einführung in die moderneDatenanalyseunter Windows, 2005, 608 p.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">GBD Disease, I Injury, C Prevalence. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet, 2018; 392 (10159): 1789–1858. doi: 10.1016/S0140-6736(18)32279-7</mixed-citation><mixed-citation xml:lang="en">GBD Disease, I Injury, C Prevalence. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet, 2018; 392 (10159): 1789–1858. doi: 10.1016/S0140-6736(18)32279-7</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Cui R. Editorial: a systematic review of depression. Cur. Neuropharmacol., 2015; 13 (4): 480. doi: 10.2174/1570159X1304150831123535</mixed-citation><mixed-citation xml:lang="en">Cui R. Editorial: a systematic review of depression. Cur. Neuropharmacol., 2015; 13 (4): 480. doi: 10.2174/1570159X1304150831123535</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Xu J., He K., Zhang K., Yang C., Nie L., Dan D., Liu J., Zhang C.E., Yang X. Low-Dose Copper Exposure Exacerbates Depression-Like Behavior in ApoE4 Transgenic Mice. Oxid. Med. Cell Longev., 2021; 2021: 6634181. doi: 10.1155/2021/6634181</mixed-citation><mixed-citation xml:lang="en">Xu J., He K., Zhang K., Yang C., Nie L., Dan D., Liu J., Zhang C.E., Yang X. Low-Dose Copper Exposure Exacerbates Depression-Like Behavior in ApoE4 Transgenic Mice. Oxid. Med. Cell Longev., 2021; 2021: 6634181. doi: 10.1155/2021/6634181</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Yamazaki Y., Zhao N., Caulfield T.R., Liu C.C., Bu G. Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Nat. Rev. Neurology., 2019; 15 (9): 501–518. doi: 10.1038/s41582-019-0228-7.</mixed-citation><mixed-citation xml:lang="en">Yamazaki Y., Zhao N., Caulfield T.R., Liu C.C., Bu G. Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Nat. Rev. Neurology., 2019; 15 (9): 501–518. doi: 10.1038/s41582-019-0228-7.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Mahley R.W. Central nervous system lipoproteins: ApoE and regulation of cholesterol metabolism. Arteriosclerosis, Thrombosis, and Vascular. Biology, 2016; 36 (7): 1305–1315. doi: 10.1161/ATVBAHA.116.307023</mixed-citation><mixed-citation xml:lang="en">Mahley R.W. Central nervous system lipoproteins: ApoE and regulation of cholesterol metabolism. Arteriosclerosis, Thrombosis, and Vascular. Biology, 2016; 36 (7): 1305–1315. doi: 10.1161/ATVBAHA.116.307023</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Ramachandran G., Marder K., Tang M., et al. A preliminary study of apolipoprotein E genotype and psychiatric manifestations of Alzheimer’s disease. Neurology, 1996; 47 (1): 256–259. doi: 10.1212/WNL.47.1.256</mixed-citation><mixed-citation xml:lang="en">Ramachandran G., Marder K., Tang M., et al. A preliminary study of apolipoprotein E genotype and psychiatric manifestations of Alzheimer’s disease. Neurology, 1996; 47 (1): 256–259. doi: 10.1212/WNL.47.1.256</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Wang W.W., Liu X.L., Ruan Y., Wang L., Bao T.H. Depression was associated with apolipoprotein E ε4 allele polymorphism: a meta-analysis. Iran. J. Basic Med. Sci., 2019; 22 (2): 112–117. doi: 10.22038/ijbms.2018. 30825.7436</mixed-citation><mixed-citation xml:lang="en">Wang W.W., Liu X.L., Ruan Y., Wang L., Bao T.H. Depression was associated with apolipoprotein E ε4 allele polymorphism: a meta-analysis. Iran. J. Basic Med. Sci., 2019; 22 (2): 112–117. doi: 10.22038/ijbms.2018. 30825.7436</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Зуева И.Б., Улитина А.С., Гораб Д.Н., Москаленко М.В., Дубина М.В. Полиморфизм гена APOE у пациентов с метаболическим синдромом и когнитивными расстройствами. Артериальная гипертензия, 2012; 18(5): 4221–428. https://doi.org/10.18705/1607-419X-2012-18-5-421-428</mixed-citation><mixed-citation xml:lang="en">Зуева И.Б., Улитина А.С., Гораб Д.Н., Москаленко М.В., Дубина М.В. Полиморфизм гена APOE у пациентов с метаболическим синдромом и когнитивными расстройствами. Артериальная гипертензия, 2012; 18(5): 4221–428. https://doi.org/10.18705/1607-419X-2012-18-5-421-428</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
